Thalidomide-O-PEG2-propargyl (E3 ligase Ligand-Linker Conjugates 32) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology
causes a dose dependent tumour static effect that can be converted into regressions when combined with MEK1 inhibition
3-oxazole-4-carboxamide hydrochloride
EPZ011989 reduces cellular H3K27 methylation in the Y641F
C4H4O4/c1-12(2)33-18(25)28-9-31-35(27
Protodioscin Size:Contact [email protected] for quotation Thalidomide-O-PEG2-propargyl (E3 ligase Ligand-Linker ConjugatesProtodioscin, a major steroidal saponin in dioscoreae rhizome, has been shown to exhibit multiple biological actions, such as anti hyperlipidemia, anti cancer, sexual effects and cardiovascular properties. Product information CAS Number: 55056 80 9 Molecular Weight: 1049. 20 Formula: C51H84O22 Chemical Name: (2R,3R,4S,5S,6R) 2 [(2R) 4 [(1S,2S,4S,6R,7S,8R,9S,12S,13R,16S) 6 hydroxy 16 {[(2R,3R,4S,5S,6R) 4 hydroxy 6 (hydroxymethyl) 3,5